| 1. |
File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med, 2010, 122(2): 130-141.
|
| 2. |
Brar NK, Niederman MS. Management of community acquired pneumonia: a review and update. Ther Adv Respir Dis, 2011, 5: 61-78.
|
| 3. |
Garnacho-Montero J, Barrero-García I, Gómez-Prieto MG, et al. Severe community-acquired pneumonia: current management and future therapeutic alternatives. Expert Rev Ant Infect Ther, 2018, 16(9): 667-677.
|
| 4. |
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019, 200(7): e45-e67.
|
| 5. |
Ilg A, Moskowitz A, Konanki V, et al. Performance of the CURB-65 score in predicting critical care interventions in patients admitted with community-acquired pneumonia. Ann Emerg Med, 2019, 74(1): 60-68.
|
| 6. |
Sharp AL, Jones JP, Wu I, et al. CURB-65 performance among admitted and discharged emergency department patients with community-acquired pneumonia. Acad Emerg Med, 2016, 23(4): 400-405.
|
| 7. |
劉玉, 張嘉瑞, 羅遠明, 等. 慢性阻塞性肺疾病急性加重合并社區獲得性肺炎短期死亡及不良結局預測模型的驗證研究. 中國呼吸與危重監護雜志, 2023, 22(3): 159-167.
|
| 8. |
符翔. 慢性阻塞性肺疾病合并重癥肺炎患者免疫功能指標和血清降鈣素原及前清蛋白檢測的臨床意義. 臨床醫藥實踐, 2020, 29(6): 430-433.
|
| 9. |
宋驕陽. 新型冠狀病毒肺炎并發靜脈血栓栓塞癥的研究進展. 中國呼吸與危重監護雜志, 2021, 20(1): 58-63.
|
| 10. |
Guan WJ, Ni ZY, Hu U, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, 382(18): 1708-1720.
|
| 11. |
Mansory EM, Srigunapalan S, Lazo-Langner A. Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis. TH Open, 2021, 5(3): e286-e294.
|
| 12. |
Roberto C, Camilla C, Marco F, et al. Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicenter observational study. Thromb Haemost, 2022, 122(2): 257-266.
|
| 13. |
Heinemann LA, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women. Contraception, 2007, 75(5): 328-336.
|
| 14. |
Nahum J, Morichau-Beauchant T, Daviaud F, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw, 2020, 3(5): e2010478.
|
| 15. |
秦立昊, 余海洋, 樸則宇, 等. 孤立性肺栓塞與深靜脈血栓相關性肺栓塞的危險因素與發病機制的研究進展. 中國呼吸與危重監護雜志, 2023, 22(11): 821-824.
|
| 16. |
徐佳麗, 胡蓓蓓, 茅秋霞, 等. 新型冠狀病毒肺炎患者的靜脈血栓栓塞癥風險評估與抗凝治療. 中國呼吸與危重監護雜志, 2021, 20(2): 101-105.
|
| 17. |
Torres A, Cilloniz C, Niederman MS, et al. Pneumonia. Nat Rev Dis Primers, 2021, 7(1): 25.
|
| 18. |
黃澤波, 曾凡喬, 江祚龍, 等. 個體化預測CRRT治療重癥肺部感染相關膿毒癥患者預后列線圖模型的建立. 臨床肺科雜志, 2022, 27(7): 1030-1041.
|
| 19. |
中華醫學會呼吸病學分會肺栓塞與肺血管病學組, 中國醫師協會呼吸醫師分會肺栓塞與肺血管病工作委員會, 全國肺栓塞與肺血管病防治協作組. 肺血栓栓塞癥診治與預防指南. 中華醫學雜志, 2018, 98(14): 1060-1087.
|
| 20. |
張煒宗, 袁紅, 孫金棟, 等. 新型冠狀病毒感染患者院內死亡危險因素的Meta分析. 中國全科醫學, 2023, 26(5): 607-620.
|
| 21. |
Wong CK, Au IC, Lau KT, et al. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet, 2022, 400(10359): 1213-1222.
|
| 22. |
Arbel R, Wolff Sagy Y, Hoshen M, et al. Nirmatrelvir use and severe Covid-19 outcomes during the omicron surge. N Engl J Med, 2022, 387(9): 790-798.
|